Advanced Medical Equipment
Precision System Science Co Ltd Expects Extraordinary Profit for FY 2014
Precision System Science Co Ltd announced that it expects JPY 3,822 million extraordinary profit on sale of investment in securities for the fiscal year ending June 2014.
Digirad Corp Announces Management Changes
Digirad Corp announced that planned transition from its previously announced restructuring plan, President Matthew G. Molchan will assume the role of Chief Executive Officer, effective July 1. Molchan has also been named a Director of the Company.
Endologix Inc Issues Q2 2013 Revenue Guidance Above Analysts' Estimates; Raises FY 2013 Revenue Guidance; Lowers FY 2013 Earnings Guidance
Endologix Inc announced that for second quarter of 2013, it expects global revenue of approximately $34.0 million. For fiscal 2013, it expects revenue to be in the range of $128-$134 million, adjusted net (loss) per share (non-GAAP) to be in the range of $(0.18) to $(0.22) per share, adjusted EBITDA...
Covidien PLC Completes Separation of Pharmaceuticals Business
Covidien PLC announced that it has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin "regular way" trading on the New York Stock Exchange under the symbol "MNK." The distribution of Mallinckrodt...
Isonea Ltd Raises $13.5 Million Via Private Placement
Isonea Ltd announced it has successfully completed a private placement with professional and sophisticated clients of Patersons Securities, at an issue price of AUD0.35 per share, raising approximately AUD13,500,000 before costs. The placement of up to 38,571,429 new fully paid ordinary shares...
Precision System Science Co Ltd Expects Extraordinary Profit and Amends Full-year Consolidated Outlook for FY 2013
Precision System Science Co Ltd announced that it expects the extraordinary profit of JPY 1,502 caused by gain on sale of investment securities, for the fiscal year ending June 2013. As a result, the Company has reaffirmed its full-year consolidated outlook for revenue of JPY 4,100 million,...
Pyng Medical Corp's FASTResponder Receives CE Mark In Europe And Cleared By FDA For Marketing In United States
Pyng Medical Corp announced that FASTResponder, its Intraosseus Infusion device, has received the CE Mark in Europe and has been cleared by the United States Food and Drug Administration (FDA) for marketing in the United States. The FASTResponder product has received initial positive input from...
Veeva Systems Inc Plans To Conduct Registered Initial Public Offering (IPO) Of Common Stock
Veeva Systems Inc announced that it plans to conduct a registered initial public offering (IPO) of its common stock. The offering is expected to commence after the Securities and Exchange Commission completes the review process initiated by Veeva Systems' confidential submission on June 26, 2013 of...
Mergers & Acquisitions
- Boston Scientific Corp To Acquire Bard's Electrophysiology Business
- Cynosure Inc Completes Acquisition Of Palomar Medical Technologies Inc
- Wright Medical Group Inc And MicroPort Scientific Corp's MicroPort Medical B.V. Enter Into Definitive Agreement Under Which MicroPort Will Acquire Wright’s OrthoRecon Business-Reuters
- USCOM Ltd Completes Pulsecor Asset Purchase and Acquires New BP+ Central Blood Pressure Device
- Mindray Medical International Ltd to Acquire ZONARE Medical Systems
- Asiamedic Ltd's Subsidiary Announces Acquisition Of Business Assets, Liabilities And Undertakings From WMB Holdings Pte
- USCOM Ltd To Acquire Pulsecor Limited And New Blood Pressure Products
- Biosensors International Group Ltd Announces Completion Of Acquisition Of Spectrum Dynamics
- Toumaz Ltd Announces Issue Of Equity In Relation To Deferred Consideration
Restructuring & Reorganization
- CHC Healthcare Group Announces Merger between Subsidiaries
- Biosensors International Group Ltd Announces Dissolution Of Dormant Subsidiary
- CHC Healthcare Group Announces Effective Date of Subsidiaries' Merger
- Japan Lifeline Co Ltd to Recall Products
- Fresenius SE & Co KGaA To Quit Biotech Unit-Reuters
- CHC Healthcare Group Announces Merger of Subsidiaries
- Olympus Corp Announces Outcome of Early Retirement Program; Expects Extraordinary Loss for Q2 of FY 2013
- Covidien PLC To Shutter South Carolina Plant, Lay Off 595-Reuters
- Olympus Corp to Offer Early-retirement Program
Expansion & New Markets
- CHC Healthcare Group to Invest in Myanmar
- Asiamedic Ltd's Subsidiary Announces Incorporation Of Wholly Owned Subsidiary
- Biosensors International Group Ltd Announces Incorporation Of New Subsidiaries
- RION CO LTD Establishes New Subsidiary in China
- Boule Diagnostics AB Establishes Subsidiary in Mexico
- Cheng Yeh Holdings Co to Invest in Mainland China
- NIHON KOHDEN CORP Establishes New Subsidiary in United States to Acquire Defibtech LLC
- Thermo Fisher Scientific Inc Opens New Manufacturing Facility In China
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  +48.23% |
| Basic Materials | +148.06% |
| Industrials | +65.85% |
| Cyclical Goods & Services | +67.15% |
| Non-Cyclical Goods & Services | +59.61% |
| Financials | +71.70% |
| Healthcare | +39.87% |
| Technology | +16.30% |
| Telecoms | +114.68% |
| Utilities | +68.03% |
| DOW | 14,974.96 | +65.36 |
+0.44% |
| S&P 500 | 1,614.96 | +8.68 |
+0.54% |
| NASDAQ | 3,434.49 | +31.24 |
+0.92% |
| TR US Index | 146.65 | +0.85 |
+0.58% |
-30.90Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
|
Provider: Renaissance Capital
|
$92.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
